Prednisolone and<i>Mycobacterium indicus pranii</i>in Tuberculous Pericarditis

M. Mayosi, Bongani; Ntsekhe, Mpiko; Bosch, Jackie; Pandie, Shaheen; Jung, Hyejung; Gumedze, Freedom; Pogue, Janice; Thabane, Lehana; Smieja, Marek; Francis, Veronica; Joldersma, Laura; M. Thomas, Kandithalal; Thomas, Baby; A Awotedu, A; Magula, Nombulelo; Naidoo, D.P.; Damasceno, Albertino; Chitsa Banda, Alfred; Brown, Basil; Manga, Pravin; Kirenga, Bruce; Mondo, Charles; Mntla, Phindile; M. Tsitsi, Jacob; Peters, Ferande; R. Essop, Mohammed; B. Russell, James; Hakim, James; Matenga, Jonathan; Felix Barasa, Ayub; U. Sani, Mahmoud; Olunuga, Taiwo; S. Ogah, Okechukwu; Ansa, Victor; Aje, Akinyemi; Danbauchi, Solomon; Ojji, Dike; Yusuf, Salim

doi:10.1056/nejmoa1407380

Public

Prednisolone andMycobacterium indicus praniiin Tuberculous Pericarditis

Published in New England Journal of Medicine • Sep 2, 2014

Authors:

Bongani M. Mayosi

Mpiko Ntsekhe

Jackie Bosch

Abstract

BACKGROUND: Tuberculous pericarditis is associated with high morbidity and mortality even if antituberculosis therapy is administered. We evaluated the effects of adjunctive glucocorticoid therapy and Mycobacterium indicus pranii immunotherapy in patients with tuberculous pericarditis. METHODS: Usin...

Subject

Medicine

Hazard ratio

Prednisolone

Research Assistant

AI chat, annotations, notes & similar papers

Finding related papers...

Discussions

(0)

No comments yet

Be the first to share your thoughts!